XTX Topco Ltd - CNS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of CNS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$6,780
-46.2%
18,729
+87.3%
0.00%
-66.7%
Q4 2023$12,60310,0020.00%
Other shareholders
CNS PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
FSM Wealth Advisors, LLC 19,084$21,7560.01%
WELLS FARGO & COMPANY/MN 505$5760.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 55$630.00%
Global Retirement Partners, LLC 53$570.00%
GEODE CAPITAL MANAGEMENT, LLC 24,436$27,3680.00%
Plante Moran Financial Advisors, LLC 1$10.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 21,428$23,9990.00%
Tower Research Capital LLC (TRC) 4,740$5,4040.00%
MORGAN STANLEY 67$760.00%
View complete list of CNS PHARMACEUTICALS INC shareholders